Marijuana

Information obtained from www.drugabuse.gov

What is marijuana?

Marijuana - often called pot, grass, reefer, weed, herb, mary jane, or mj - is a greenish-gray mixture of the dried, shredded leaves, stems, seeds, and flowers of Cannabis sativa , the hemp plant. Most users smoke marijuana in hand-rolled cigarettes called joints , among other names; some use pipes or water pipes called bongs . Marijuana cigars called blunts have also become popular. To make blunts, users slice open cigars and replace the tobacco with marijuana, often combined with another drug, such as crack cocaine. 23 Marijuana also is used to brew tea and is sometimes mixed into foods.

The major active chemical in marijuana is delta-9-tetrahydrocannabinol (THC), which causes the mind-altering effects of marijuana intoxication. The amount of THC (which is also the psychoactive ingredient in hashish) determines the potency and, therefore, the effects of marijuana. Between 1980 and 1997, the amount of THC in marijuana available in the United States rose dramatically. 24

What is the scope of marijuana use in the United States?

Marijuana is the Nation's most commonly used illicit drug. More than 83 million Americans (37 percent) age 12 and older have tried marijuana at least once, according to the 2001 National Household Survey on Drug Abuse (NHSDA). 25

Marijuana use is widespread among adolescents and young adults. The percentage of middle-school students who reported using marijuana increased throughout the early 1990s. 26 In the past few years, according to the 2001 Monitoring the Future Study, an annual survey of drug use among the Nation's middle- and high-school students, illicit drug use by 8th-, 10th-, and 12th-graders has leveled off. 26 Still, in 2001, 20 percent of 8th-graders reported that they had tried marijuana, and 9 percent were current users (defined as having used the drug in the 30 days preceding the survey). 26 Among 10th-graders, 40 percent had tried marijuana sometime in their lives, and almost 20 percent were current users. 26 As would be expected, rates of use among 12th-graders were higher still: Nearly half had tried marijuana at some time, and 22 percent were current users. 26

The Drug Abuse Warning Network (DAWN), a system for monitoring the health impact of drugs, estimated that, in 2001, marijuana was a contributing factor in more than 110,000 emergency department (ED) visits in the United States, with about 15 percent of the patients between the ages of 12 and 17, and almost two-thirds male. 27

In 1999, the National Institute of Justice's Arrestee Drug Abuse Monitoring Program (ADAM), which collects data from 34 sites on the number of adult arrestees testing positive for various drugs, found that, on average, 39 percent of adult male arrestees and 26 percent of adult female arrestees tested positive for marijuana. 28 ADAM collected data on juvenile arrestees in nine sites and found that marijuana was the most commonly used drug among these youths. On average, 53 percent of juvenile male and 38 percent of juvenile female arrestees tested positive for marijuana.

NIDA's Community Epidemiology Work Group (CEWG), a network of researchers that tracks trends in the nature and patterns of drug use in major U.S. cities, consistently reports that marijuana frequently is combined with other drugs, such as crack cocaine, PCP, formaldehyde, and codeine cough syrup, sometimes without the user being aware of it. 23 Thus, the risks associated with marijuana use may be compounded by the risks of added drugs, as well.

Go back to top

How does marijuana affect the brain?

Scientists have learned a great deal about how THC acts in the brain to produce its many effects. When someone smokes marijuana, THC rapidly passes from the lungs into the bloodstream, which carries the chemical to organs throughout the body, including the brain. In the brain, THC connects to specific sites called cannabinoid receptors on nerve cells and thereby influences the activity of those cells. Some brain areas have many cannabinoid receptors; others have few or none. Many cannabinoid receptors are found in the parts of the brain that influence pleasure, memory, thought, concentration, sensory and time perception, and coordinated movement. 29

Go back to top

What are the acute effects of marijuana use?

Marijuana's effects begin immediately after the drug enters the brain and last from 1 to 3 hours. If marijuana is consumed in food or drink, the short-term effects begin more slowly, usually in 1/2 to 1 hour, and last longer, for as long as 4 hours. Smoking marijuana deposits several times more THC into the blood than does eating or drinking the drug. 30

Within a few minutes after inhaling marijuana smoke, an individual's heart begins beating more rapidly, the bronchial passages relax and become enlarged, and blood vessels in the eyes expand, making the eyes look red. The heart rate, normally 70 to 80 beats per minute, may increase by 20 to 50 beats per minute or, in some cases, even double. 16 This effect can be greater if other drugs are taken with marijuana. 31

As THC enters the brain, it causes a user to feel euphoric - or "high" - by acting in the brain's reward system, areas of the brain that respond to stimuli such as food and drink as well as most drugs of abuse. THC activates the reward system in the same way that nearly all drugs of abuse do, by stimulating brain cells to release the chemical dopamine. 32 , 33 , 34

A marijuana user may experience pleasant sensations, colors and sounds may seem more intense, and time appears to pass very slowly. The user's mouth feels dry, and he or she may suddenly become very hungry and thirsty. His or her hands may tremble and grow cold. The euphoria passes after awhile, and then the user may feel sleepy or depressed. Occasionally, marijuana use produces anxiety, fear, distrust, or panic.

Marijuana use impairs a person's ability to form memories, recall events (see Marijuana, Memory, and the Hippocampus), and shift attention from one thing to another. 8 , 35 THC also disrupts coordination and balance by binding to receptors in the cerebellum and basal ganglia, parts of the brain that regulate balance, posture, coordination of movement, and reaction time. 11 Through its effects on the brain and body, marijuana intoxication can cause accidents. Studies show that approximately 6 to 11 percent of fatal accident victims test positive for THC. In many of these cases, alcohol is detected as well. 36 , 37 , 38

In a study conducted by the National Highway Traffic Safety Administration, a moderate dose of marijuana alone was shown to impair driving performance; however, the effects of even a low dose of marijuana combined with alcohol were markedly greater than for either drug alone 39 . Driving indices measured included reaction time, visual search frequency (driver checking side streets), and the ability to perceive and/or respond to changes in the relative velocity of other vehicles.

Marijuana users who have taken high doses of the drug may experience acute toxic psychosis, which includes hallucinations, delusions, and depersonalization - a loss of the sense of personal identity, or self-recognition. 10 , 16 Although the specific causes of these symptoms remain unknown, they appear to occur more frequently when a high dose of cannabis is consumed in food or drink rather than smoked.

Go back to top

How does marijuana use affect physical health?

Marijuana use has been shown to increase users' difficulty in trying to quit smoking tobacco. 40 This was recently reported in a study comparing smoking cessation in adults who smoked both marijuana and tobacco with those who smoked only tobacco. The relationship between marijuana use and continued smoking was particularly strong in those who smoked marijuana daily at the time of the initial interview, 13 years prior to the followup interview.

A study of 450 individuals found that people who smoke marijuana frequently but do not smoke tobacco have more health problems and miss more days of work than nonsmokers do. 41 Many of the extra sick days used by the marijuana smokers in the study were for respiratory illnesses.

Even infrequent marijuana use can cause burning and stinging of the mouth and throat, often accompanied by a heavy cough. Someone who smokes marijuana regularly may have many of the same respiratory problems that tobacco smokers do, such as daily cough and phlegm production, more frequent acute chest illnesses, a heightened risk of lung infections, and a greater tendency toward obstructed airways. 4

Cancer of the respiratory tract and lungs may also be promoted by marijuana smoke. 4 A study comparing 173 cancer patients and 176 healthy individuals produced strong evidence that smoking marijuana increases the likelihood of developing cancer of the head or neck, and that the more marijuana smoked, the greater the increase. 18 A statistical analysis of the data suggested that marijuana smoking doubled or tripled the risk of these cancers.

Marijuana has the potential to promote cancer of the lungs and other parts of the respiratory tract because it contains irritants and carcinogens. 42 In fact, marijuana smoke contains 50 percent to 70 percent more carcinogenic hydrocarbons than does tobacco smoke. 43 It also produces high levels of an enzyme that converts certain hydrocarbons into their carcinogenic form, levels that may accelerate the changes that ultimately produce malignant cells. 44 Marijuana users usually inhale more deeply and hold their breath longer than tobacco smokers do, which increases the lungs' exposure to carcinogenic smoke. These facts suggest that, puff for puff, smoking marijuana may increase the risk of cancer more than smoking tobacco does.

Some adverse health effects caused by marijuana may occur because THC impairs the immune system's ability to fight off infectious diseases and cancer. In laboratory experiments that exposed animal and human cells to THC or other marijuana ingredients, the normal disease-preventing reactions of many of the key types of immune cells were inhibited. 17 In other studies, mice exposed to THC or related substances were more likely than unexposed mice to develop bacterial infections and tumors. 15 , 45

One study has indicated that a person's risk of heart attack during the first hour after smoking marijuana is four times his or her usual risk. 46 The researchers suggest that a heart attack might occur, in part, because marijuana raises blood pressure and heart rate and reduces the oxygen-carrying capacity of blood.

How does marijuana use affect school, work, and social life?

Students who smoke marijuana get lower grades and are less likely to graduate from high school, compared with their nonsmoking peers. 22 , 47 , 48 , 49

Workers who smoke marijuana are more likely than their co-workers to have problems on the job. Several studies have associated workers' marijuana smoking with increased absences, tardiness, accidents, workers' compensation claims, and job turnover. A study among municipal workers found that employees who smoked marijuana on or off the job reported more "withdrawal behaviors" - such as leaving work without permission, daydreaming, spending work time on personal matters, and shirking tasks - that adversely affect productivity and morale. 50

Depression 19 , anxiety 19 , 20 , and personality disturbances 5 are all associated with marijuana use. Research clearly demonstrates that marijuana use has the potential to cause problems in daily life or make a person's existing problems worse. Because marijuana compromises the ability to learn and remember information, the more a person uses marijuana the more he or she is likely to fall behind in accumulating intellectual, job, or social skills. In one study of cognition, adults were matched on the basis of their performance in the 4th grade on the Iowa Test of Basic Skills. They were evaluated on a number of cognitive measures including the 12th grade version of the Iowa Test. Those who were heavy marijuana smokers scored significantly lower on mathematical skills and verbal expression than non-smokers. 9

Moreover, research has shown that marijuana's adverse impact on memory and learning can last for days or weeks after the acute effects of the drug wear off. 9 , 35 For example, a study of 129 college students found that among heavy users of marijuana, those who smoked the drug at least 27 of the preceding 30 days, critical skills related to attention, memory, and learning were significantly impaired, even after they had not used the drug for at least 24 hours. 35 The heavy marijuana users in the study had more trouble sustaining and shifting their attention and in registering, organizing, and using information than did the study participants who had used marijuana no more than 3 of the previous 30 days. As a result, someone who smokes marijuana once daily may be functioning at a reduced intellectual level all of the time. More recently, the same researchers showed that a group of long-term heavy marijuana users' ability to recall words from a list was impaired 1 week following cessation of marijuana use, but returned to normal by 4 weeks. 52 An implication of this finding is that even after long-term heavy marijuana use, if an individual quits marijuana use, some cognitive abilities may be recovered.

Another study produced additional evidence that marijuana's effects on the brain can cause cumulative deterioration of critical life skills in the long run. Researchers gave students a battery of tests measuring problem-solving and emotional skills in 8th grade and again in 12th grade. 53 The results showed that the students who were already drinking alcohol plus smoking marijuana in 8th grade started off slightly behind their peers but that the distance separating these two groups grew significantly by their senior year in high school. The analysis linked marijuana use, independently of alcohol use, to reduced capacity for self-reinforcement, a group of psychological skills that enable individuals to maintain confidence and persevere in the pursuit of goals.

Go back to top

Can marijuana use during pregnancy harm the baby?

Research has shown that babies born to women who used marijuana during their pregnancies display altered responses to visual stimuli, increased tremulousness, and a high-pitched cry, which may indicate problems with neurological development. 54 During infancy and preschool years, marijuana-exposed children have been observed to have more behavioral problems and to perform tasks of visual perception, language comprehension, sustained attention, and memory more poorly than nonexposed children do. 55 , 56 In school, these children are more likely to exhibit deficits in decision-making skills, memory, and the ability to remain attentive. 55 , 56

Go back to top

Is marijuana use addictive?

Long-term marijuana use can lead to addiction for some people; that is, they use the drug compulsively even though it often interferes with family, school, work, and recreational activities. According to the 2001 National Household Survey on Drug Abuse, an estimated 5.6 million Americans age 12 or older reported problems with illicit drug use in the past year. Of these, 3.6 million met diagnostic criteria for dependence on an illicit drug. More than 2 million met diagnostic criteria for dependence on marijuana/hashish. 57 In 1999, more than 220,000 people entering drug abuse treatment programs reported that marijuana was their primary drug of abuse. 58

Along with craving, withdrawal symptoms can make it hard for long-term marijuana smokers to stop using the drug. People trying to quit report irritability, difficulty sleeping, and anxiety. 59 , 60 They also display increased aggression on psychological tests, peaking approximately 1 week after they last used the drug. 61

Go back to top

What treatments are available for marijuana abusers?

Treatment programs directed at marijuana abuse are rare, partly because many who use marijuana do so in combination with other drugs, such as cocaine and alcohol. However, with more people seeking help to control marijuana abuse, research has focused on ways to overcome problems with abuse of this drug. 62

One study of adult marijuana users found comparable benefits from a 14-session cognitive-behavioral group treatment and a 2-session individual treatment that included motivational interviewing and advice on ways to reduce marijuana use. 63 Participants were mostly men in their early thirties who had smoked marijuana daily for over 10 years. By increasing patients' awareness of what triggers their marijuana use, both treatments sought to help them devise avoidance strategies. Use, dependence symptoms, and psychosocial problems decreased for at least 1 year after both treatments. About 30 percent of users were abstinent during the last 3-month followup period. Another study suggests that giving patients vouchers for abstaining from marijuana can improve outcomes. 64 Vouchers can be redeemed for such goods as movie passes, sports equipment, or vocational training.

No medications are now available to treat marijuana abuse. However, recent discoveries about the workings of THC receptors have raised the possibility that scientists may eventually develop a medication that will block THC's intoxicating effects. Such a medication might be used to prevent relapse to marijuana abuse by reducing or eliminating its appeal.

Go back to top

Where can I get further scientific information about marijuana?

Fact sheets on marijuana, other illicit drugs, and related topics are available free, in English and Spanish, by calling NIDA Infofax at 1-888-NIH-NIDA (1-888-644-6432) or, for those with hearing impairment, 1-888-TTY-NIDA (1-888-889-6432).

Information on marijuana and related topics also can be obtained through NIDA's home page, www.drugabuse.gov , and from the National Clearinghouse for Alcohol and Drug Information (NCADI) at 1-800-729-6686. NCADI's Web site is www.health.org .

Go back to top

Glossary

Addiction: A chronic, relapsing disease characterized by compulsive drug-seeking and abuse and by long-lasting chemical changes in the brain.

Cannabinoids: Chemicals that help control mental and physical processes when produced naturally by the body and that produce intoxication and other effects when absorbed from marijuana.

Carcinogen: Any substance that causes cancer.

Dopamine: A brain chemical, classified as a neurotransmitter, found in regions of the brain that regulate movement, emotion, motivation, and pleasure.

Hippocampus: An area of the brain crucial for learning and memory.

Hydrocarbon: Any chemical compound containing only hydrogen and carbon.

Psychoactive: Having a specific effect on the mind.

THC: Delta-9-tetrahydrocannabinol; the main active ingredient in marijuana, which acts on the brain to produce its effects.

Withdrawal: Symptoms that occur after use of a drug is reduced or stopped.

Go back to top

References

1 Johnston, L.D.; O'Malley, P.M.; and Bachman, J.G. Monitoring the Future; National Results on Adolescent Drug Use, Overview and Key findings, 2000 . NIH Pub. No. 01-4923. Bethesda, MD: NIDA, NIH, DHHS, 2000.

2 Substance Abuse and Mental Health Services Administration. Technical appendices and Selected Data Tables: Results from the 2001 National Household Survey on Drug Abuse . NHSDA Series H-18. DHHS Pub. No. (SMA) 02-3759. Rockville, MD: DHHS, 2002.

3 ElSohly, M.A., and Ross, S.A. Quarterly report: Potency monitoring project. November 2002, unpublished.

4 Tashkin, D.P. Pulmonary complications of smoked substance abuse. West J Med 152:525-530, 1990.

5 Sarafian, T.A.; Magallanes, J.A.; Shau, H.; Tashkin, D.; and Roth, M.D. Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids. Am J Respir Cell Mol Biol 20(6):1286-1293, 1999.

6 Roth, M.D.; Arora, A.; Barsky, S.H.; Kleerup, E.C.; Simmons, M.; and Tashkin, D.P. Airway inflammation in young marijuana and tobacco smokers. Am. J. Respir Crit Care Med 157:928-937, 1998.

7 Heishman, S.J.; Arasteh, K; and Stitzer, M.L. Comparative effects of alcohol and marijuana on mood, memory, and performance. Pharmacol Biochem Behav 58:97-101, 1997.

8 Fletcher, J.M.; Page, J.B.; Francis, D.J.; Copeland, K.; Naus, M.J.; Davis, C.M.; Morris, R.; Krauskopf, D.; and Santz, P. Cognitive correlates of chronic cannabis use in Costa Rican men. Archives of General Psychiatry 53:1051-1057, 1996.

9 Block, R.I., and Ghoneim, M.M. Effects of chronic marijuana use on human cognition. Psychopharmacology 100(1-2): 219-228, 1993.

10 Graham, A.W.; Schultz, T.K.; and Wilford, B.B. (eds.). Principles of Addiction Medicine, 2nd Edition . Chevy Chase, MD: American Society of Addiction Medicine, Inc., 1998.

11 Ameri, A. The effects of cannabinoids on the brain. Prog Neurobiol 58(4):315-348, 1999.

12 Patrick, G., and Struve, F.A. Reduction of auditory P50 gating response in marihuana users: further supporting data. Clin Electroencephalogr 31(2):88-93, 2000.

13 Jones, R.T., et al. Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 21(8-9 Suppl):143S-152S, 1981.

14 Srivistava, M.D.; Srivastava, B.I.; and Brouhard, B. Delta-9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology 40(3):179-185, 1998.

15 Zhu, L.X.; Stolina, M.; Sharma, S.; Gardner, B.; Roth, M.D.; Tashkin, D.P.; and Dubinett, S.M. Delta-9 tetrahydrocannabinol inhibits antitumor immunity by a CB-2 receptor-mediated, cytokine dependent-pathway. J Immunology 165(1):373-380, 2000.

16 Gilman, A.G.; Rall, T.W.; Nies, A.S.; and Taylor, P. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th Edition . New York: Pergamon Press, 1998.

17 Adams, I.B., and Martin, B.R. Cannabis: Pharmacology and toxicology in animals and humans. Addiction 91:1585-1614, 1996.

18 Zhang, Z.-F.; Morgenstern, H.; Spitz, M.R.; Tashkin, D.P.; Yu, G.-P.; Marshall, J.R.; Hsu, T.C; and Stimson, P.S. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiology, Biomarkers & Prevention 6:1071-1078, 1999.

19 Brook, J.S., et al. The effect of early marijuana use on later anxiety and depressive symptoms. NYS Psychologist January:35-39, 2001.

20 Green, B.E., and Ritter, C. Marijuana use and depression. J Health Soc Behav 41(1):40-49, 2000.

21 Wilson, W.; Mathew, R.; Turkington, T.; Hawk, T.; Coleman, R.E.; and Provenzale, J. Brain morphological changes and early marijuana use: A magnetic resonance and positron emission tomography study. J Addict Dis 19(1):1-22, 2000.

22 Brook, J.S.; Balka, E.B.; and Whiteman, M. The risks for late adolescence of early adolescent marijuana use. Am J Public Health 89(10):1549-1554, 1999.

23 Community Epidemiology Work Group. Epidemiologic Trends in Drug Abuse, June 2000. Vol. 1, Highlights and Executive Summary. NIH Pub. No. 00-4739A. Bethesda, MD: NIDA, NIH, DHHS, 2000.

24 ElSohly, M.A.; Ross, S.A.; Mehmedic, Z.; Arafat, R.; Yi, B.; and Banahan, B. Potency trends of delta-9-THC and other cannabinoids in confiscated marijuana from 1980-1997. Journal of Forensic Sciences 45(1):24-30, 2000.

25 Office of Applied Studies. Results from the 2001 National Household Survey on Drug Abuse: Volume II. Technical Appendices and Selected Data Tables . NHSDA Series H-18. DHHS Pub. No. (SMA) 02-3759. Rockville, MD: SAMHSA, 2002.

26 Johnston, L.D.; O'Malley, P.M.; and Bachman, J.G. Monitoring the Future: National Survey Results on Drug Use, 1975-2001. Volume I: Secondary School Students . NIH Pub. No. 02-5106. Bethesda, MD: NIDA, NIH, DHHS, 2002.

27 Office of Applied Studies. Year-end 2000 Emergency Department Data from the Drug Abuse Warning Network (Table 24). DAWN Series D-18; DHHS Pub. No. (SMA) 01-3532. Rockville, MD: SAMHSA, 2001.

28 National Institute of Justice, Arrestee Drug Abuse Monitoring Program. 1999 Annual Report on Drug Use Among Adult and Juvenile Arrestees . Washington, DC: U.S. Department of Justice, June 2000.

29 Herkenham, M.; Lynn, A.; Little, M.D.; Johnson, M.R.; Melvin, L.S.; de Costa, B.R.; and Rice K.C. Cannabinoid receptor localization in the brain. Proc Natl Acad Sci, USA . 87:1932-1936, 1990.

30 Ohlsson, A.; Lindgren, J.E.; Wahlen, A.; Agurell, S.; Hollister, L.E.; and Gillespie, H.K. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28(3):409-416, 1980.

31 Foltin, R.W.; Fischman, M.W; Pedroso, J.J.; and Pearlson, G.D. Marijuana and cocaine interactions in humans: cardiovascular consequences. Pharmacol Biochem Behav 28(4):459-464,1987.

32 Chen, J.P.; Paredes, W.; Li, J.; Smith, D.; Lowinson, J.; and Gardner, E.L. Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 102:156-162, 1990.

33 French, E.D.; Dillon, K.; and Wu, X. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neurosci Lett 226:159-162, 1997.

34 Leshner, A.I., and Koob, G.F. Drugs of abuse and the brain. Proc Assoc Amer Physicians 111:99-108, 1999.

35 Pope, H.G., and Yurgelun-Todd, D. The residual cognitive effects of heavy marijuana use in college students. JAMA 272(7):521-527, 1996.

36 Mason, A.P., and McBay, A.J. Ethanol, marijuana, and other drug use in 600 drivers killed in single-vehicle crashes in North Carolina, 1978Ð1981. J Forensic Sci 29(4):987-1026, 1984.

37 Williams, A.F.; Peat, M.A.; Crouch, D.J.; Wells, J.K.; and Finkle, B.S. Drugs in fatally injured young male drivers. Public Health Report 100:19-25, 1985.

38 Cimbura, G.; Lucas, D.M.; Bennett, R.C.; and Donelson, A.C. Incidence and toxicological aspects of cannabis and ethanol detected in 1,394 fatally injured drivers and pedestrians in Ontario (1982Ð1984). J Forensic Sci 35:1035-1041, 1990.

39 National Highway Traffic Safety Administration (NHSTA) Notes. Marijuana and alcohol combined severely impede driving performance. Annals of Emergency Medicine 35(4):398-399, 2000.

40 Ford, D.E.; Vu, H.T.; and Anthony, J.C. Marijuana use and cessation of tobacco smoking in adults from a community sample. Drug and Alcohol Dependence 67:243-248, 2002.

41 Polen, M.R; Sidney, S.; Tekawa, I.S.; Sadler. M.; and Friedman, G.D. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med 158:596-601, 1993.

42 Sridhar, K.S.; Raub, W.A.; Weatherby, N.L., Jr.; Metsch, L.R.; Surratt, H.L.; Inciardi, J.A.; Duncan, R.C.; Anwyl, R.S.; and McCoy, C.B. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. Journal of Psychoactive Drugs 26(3):285-288, 1994.

43 Hoffman, D.; Brunnemann, K.D.; Gori, G.B.; and Wynder, E.E.L. On the carcinogenicity of marijuana smoke. In: V.C. Runeckles, ed., Recent Advances in Phytochemistry . New York: Plenum, 1975.

44 Cohen, S. Adverse effects of marijuana: Selected issues. Annals of the New York Academy of Sciences 362:119-124, 1981.

45 Klein, T.W.; Newton, C.; and Friedman, H. Resistance to Legionella pneumophila suppressed by the marijuana component, tetrahydrocannabinol. Journal of Infectious Disease 169:1177-1179, 1994.

46 Mittleman, M.A.; Lewis, R.A.; Maclure, M.; Sherwood, J.B.; and Muller, J.E. Triggering myocardial infarction by marijuana. Circulation 103:2805-2809, 2001.

47 Lynskey. M., and Hall, W. The effects of adolescent cannabis use on educational attainment: A review. Addiction 95(11):1621-1630, 2000.

48 Kandel, D.B., and Davies, M. High school students who use crack and other drugs. Arch Gen Psychiatry 53(1):71-80, 1996.

49 Rob, M.; Reynolds, I.; and Finlayson, P.F. Adolescent marijuana use: Risk factors and implications. Aust NZ J Psychiatry 24(1):45-56, 1990.

50 Lehman, W.E., and Simpson, D.D. Employee substance abuse and on-the-job behaviors. Journal of Applied Psychology 77(3):309-321, 1992.

51 Brook, J.S.; Cohen, P.; and Brook, D.W. Longitudinal study of co-occurring psychiatric disorders and substance use. J Acad Child and Adolescent Psych 37:322-330, 1998.

52 Pope, H.G.; and Gruber, A.J.; Hudson, J.I.; Huestis, M.A.; and Yurgelun-Todd. D. Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry. Arch Gen Psychiatry 58(10):909-915, 2001.

53 Scheier, L.M., and Botvin, G.J. Effects of early adolescent drug use on cognitive efficacy in early-late adolescence: A developmental structural model. Journal of Substance Abuse 7(4):397-404, 1996.

54 Lester, B.M., and Dreher, M. Effects of marijuana use during pregnancy on newborn cry. Child Development 60:764-771, 1989.

55 Fried, P.A. The Ottawa prenatal prospective study (OPPS): Methodological issues and findingsÑit's easy to throw the baby out with the bath water. Life Sciences 56:2159-2168, 1995.

56 Fried, P.A. Prenatal exposure to marihuana and tobacco during infancy, early and middle childhood: Effects and an attempt at synthesis. Arch Toxicol Suppl 17:233-60, 1995.

57 Office of Applied Studies. National and State Estimates of the Drug Abuse Treatment Gap: 2000 National Household Survey on Drug Abuse . NHSDA Series H-14. DHHS Pub. No. (SMA) 02-3640. Rockville, MD: SAMHSA, 2002.

58 Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS): 1994-1999, National Admissions to Substance abuse Treatment Services . DASIS Series: S-14, DHHS Pub. No. (SMA) 01-3550. Rockville, MD: DHHS, 2001.

59 Haney, M.; Ward, A.S.; Comer, S.D.; Foltin, R.W.; and Fischman, M.W. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology 141:395-404, 1999.

60 Budney, A.J.; Hughes, J.R.; Moore, B.A.; and Novy, P.L. Marijuana abstinence effects in marijuana smokers maintained in their environment. Arch Gen Psychiatry 58:917-924, 2001.

61 Kouri, E.M.; Pope, H.G.; and Lukas, S.E. Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology 143:302-308, 1999.

62 Steinberg, K.L.; Roffman, R.A.; Carroll, K.M.; Kabela, E.; Kadden, R.; Miller, M.; and Duresky, D. The Marijuana Treatment Project Research Group. Tailoring cannabis dependence treatment for a diverse population. Addiction 97(Suppl 1):135-142, 2002.

63 Stephens, R.S.; Roffman R.A.; and Curtin, L. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol 68(5):898-908, 2000.

64 Budney, A.J.; Higgins, S.T.; Radonovich, K.J.; and Novy PL. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 68(6):1051-1061, 2000.

65 Heyser, C.J.; Hampson, R.E.; and Deadwyler, S.A. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: Alterations in short-term memory associated with changes in task-specific firing of hippocampal cells. Journal of Pharmacology & Experimental Therapeutics 264(1):294-307, 1993.

66 Landfield, P.W.; Cadwallader, L.B.; and Vinsant, S. Quantitative changes in hippocampal structure following long exposure to delta-9-tetrahydrocannabinol: Possible mediation of glucocorticoid systems. Brain Res 443(1-2):47-62, 1988.

67 Eldridge, J.C.; Murphy, L.L.; and Landfield, P.W. Cannabinoids and the hippocampal glucocorticoid receptor: recent findings and possible significance. Steroids 56:226-230, 1991.

68 Landfield, P.W.; Waymire, J.C.; and Lynch, G. Hippocampal aging and adrenocorticoids: quantitative correlations. Science 202:1098-1101, 1978.

69 Walker, M.J.; Huang, S.M.; Strangman, N.M.; Tsou, K.; and Sanudo-Pena, M.C. Pain modulation by the release of the endogenous cannabinoid anandamide. Proceedings of the National Academy of Sciences 96(21):12198-12203, 1999.

70 Wenger, T.; Toth, B.E.; Juaneda, C.; Leonardelli, J.; and Tramu, G. The effects of cannabinoids on the regulation of reproduction. Life Sci 65(6-7):695-701, 1999.

71 Lawston, J.; Borella, A.; Robinson, J.K.; and Whitaker-Azmitia, P.M. Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55, 212-2. Brain Research 877:407-410, 2000.

72 Chan, G.C.K.; Hinds, T.R.; Impey, S.; and Storm, D.R. Hippocampal neurotoxicity of delta-9-tetrahydrocannabinol. J Neuroscience 18(14):5322-5332, 1998.

73 Piomelli, D.; Giuffrida, A.; Calignano, A.; and Rodriguez de Fonseca, F. The endocannabinoid system as a target for therapeutic drugs. TIPS 21:218-224, 2000.

Go back to top